## Abbreviations  
* [1] [PERSON] [PERSON]; [PERSON]; [PERSON] Stem cells in cancer initiation and progression. _J. Cell Biol._**2020**, _219_, e201911053. [CrossRef] [PubMed]
* [2] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Cancer stem cell definitions and terminology: The devil is in the details. _Nat. Rev. Cancer_**2012**, _12_, 767-775. [CrossRef]
* [3] [PERSON]; [PERSON]; [PERSON] The Gli code: An information nexus regulating cell fate, stemness and cancer. _Trends Cell Biol._**2007**, _17_, 438-447. [CrossRef]
* [4] [PERSON]; [PERSON] Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. _J. Mol. Cell. Biol._**2010**, \(2\), 84-95. [CrossRef]
* [5] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. _EMBO J._**2010**, _29_, 2659-2674. [CrossRef] [PubMed]
* [6] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. _EMBO Mol. Med._**2009**, \(1\), 338-351. [CrossRef]
* [7] [PERSON]; [PERSON] Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy. _Semin. Cell Dev. Biol._**2014**, _33_, 93-104. [CrossRef]
* [8] [PERSON]; [PERSON] Hedgehog beyond medulloblastoma and basal cell carcinoma. _Biochim. Biophys. Acta_**2010**, _1805_, 181-208. [CrossRef]
* [9] [PERSON]; [PERSON] Gli proteins in development and disease. _Annu. Rev. Cell Dev. Biol._**2011**, _27_, 513-537. [CrossRef] [PubMed]
* [10] [PERSON]; [PERSON] Hedgehog signaling in development and cancer. _Dev. Cell_**2008**, _15_, 801-812. [CrossRef] [PubMed]
* [11] [PERSON]; [PERSON] Hedgehog signaling and congenital malformations. _Clin. Genet._**2005**, _67_, 193-208. [CrossRef]
* [12] [PERSON]; [PERSON]; [PERSON] Patched1 regulates hedgehog signaling at the primary cilium. _Science_**2007**, _317_, 372-376. [CrossRef]
* [13] [PERSON]; [PERSON]; [PERSON]; [PERSON] GLI transcription factors: Mediators of oncogenic Hedgehog signalling. _Eur. J. Cancer_**2006**, _42_, 437-445. [CrossRef] [PubMed]
* [14] [PERSON]; [PERSON] Hedgehog signaling: From the Drosophila cuticle to anti-cancer drugs. _Dev. Cell_**2005**, \(8\), 143-151. [CrossRef] [PubMed]
* [15] [PERSON]; [PERSON] Communating with Hedgehogs. _Nat. Rev. Mol. Cell Biol._**2005**, \(6\), 306-317. [CrossRef]
* [16] [PERSON]; [PERSON] The primary cilium: A signalling centre during vertebrate development. _Nat Rev Genet._**2010**, _11_, 331-344. [CrossRef]
* [17] [PERSON]; [PERSON]; [PERSON] Microtubule motors drive hedgehog signaling in primary cilia. _Trends Cell Biol._**2017**, _27_, 110-125. [CrossRef]
* [18] [PERSON]; [PERSON]; [PERSON] Advanced treatment for basal cell carcinomas. _Cold Spring Harb. Perspect. Med._**2014**, \(4\), a013581. [CrossRef] [PubMed]
* [19] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: Final results from the multicrature, randomised, double-blind, placebo-controlled, phase 2 trial. _Lancet Oncol._**2016**, _17_, 1720-1731. [CrossRef]
* [20] [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. _N. Engl. J. Med._**2009**, _361_, 1164-1172. [CrossRef]
* [21] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): A multicentre, randomised, double-blind phase 2 trial.